Prevalence of Sarcopenia and Its Geriatric Features
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcopenia
- Sponsor
- Brugmann University Hospital
- Enrollment
- 834
- Locations
- 1
- Primary Endpoint
- Prevalence of sarcopenia
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward.
Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice.
In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.
Investigators
Murielle Surquin
Head of clinic
Brugmann University Hospital
Eligibility Criteria
Inclusion Criteria
- •To be admitted in the unit 83 of the Geriatric Departement of the CHU Brugmann hospital, from 10/01/2016 till 30/03/2017.
Exclusion Criteria
- •Patients unable to consent or without representatives
- •Patients unable to perform the hand- grip test, the walk test or measurement of the body components by DEXA
- •Patients in severe pain
- •Bedridden patients
- •Patients for which a clear therapeutic abstention has been established
- •Language barriere that cannot be overcome
- •Patients unable to walk without the help of a third person
Outcomes
Primary Outcomes
Prevalence of sarcopenia
Time Frame: From 10/01/2016 till 30/03/2017 (up to 15 months)
Sarcopenia detection will be performed at the end of each hospitalization stay in unit 83 of the CHU Brugmann Hospital (Geriatry Department)
Secondary Outcomes
- Percentage of hospitalized patients unable to perform the sarcopenia detection test(From 10/01/2016 till 30/03/2017 (up to 15 months))